|
ヤマナカ ヒサシ
Yamanaka Hisashi
山中 寿 所属 医学部 医学科（東京女子医科大学病院） 職種 客員教授 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読なし |
| 表題 | Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study. |
| 掲載誌名 | 正式名：Modern rheumatology 略 称：Mod Rheumatol ISSNコード：(1439-7609)1439-7595(Linking) |
| 掲載区分 | 国外 |
| 巻・号・頁 | 27(2),pp.217-226 |
| 著者・共著者 | Ishiguro Naoki, Atsumi Tatsuya, Harigai Masayoshi, Mimori Tsuneyo, Nishimoto Norihiro, Sumida Takayuki, Takeuchi Tsutomu, Tanaka Yoshiya, Nakasone Ayako, Takagi Nobuhiro, Yamanaka Hisashi |
| 発行年月 | 2017/03 |
| 概要 | These data validate the importance of TCZ treatment in the early stages of RA in biologic-naive patients to achieve increased effectiveness. The safety profile of TCZ was reconfirmed. Furthermore, TCZ therapy may allow discontinuation of concomitant MTX and GCs without affecting remission. |
| DOI | 10.1080/14397595.2016.1206507 |
| PMID | 27414105 |